$113.99
| Ipamorelin | CJC-1295 No Dac |
| Unit Size 10mg: 4mg | 6mg |
| Unit Quantity: 1/2 Amber Vial | 1/2 Amber Vial |
| Molecular Formula: C38H49N9O5 | C152H252N44O42 |
| Molecular Weight: 711.9 | 3367.9 |
| Sequence: H-Aib-His-D-2Nal-D-Phe-Lys-NH2 | H-DL-Tyr-DL-Ala-DL-Asp-DL-Ala-DL-xiIle-DL-Phe-DL-xiThr-DL-Gln-DL-Ser-DL-Tyr-DL-Arg-DL-Lys-DL-Val-DL-Leu-DL-Ala-DL-Gln-DL-Leu-DL-Ser-DL-Ala-DL-Arg-DL-Lys-DL-Leu-DL-Leu-DL-Gln-DL-Asp-DL-xiIle-DL-Leu-DL-Ser-DL-Arg-NH2 |
| Appearance: White Powder | White Powder |
| Peptide Purity: >98.1% | >98.1% |
| Solubility: Soluble in water or 1% acetic acid | Soluble in water or 1% acetic acid |
.
Ipamorelin, a selective growth hormone-releasing peptide (GHRP), stimulates pituitary growth hormone (GH) secretion by binding ghrelin receptors (GHSR), activating G-protein-coupled signaling without significantly elevating cortisol or prolactin. This promotes muscle growth, fat loss, tissue repair, and bone density, making it a preferred GHRP for body composition and anti-aging applications.
CJC-1295, a synthetic growth hormone-releasing hormone (GHRH) analog, stimulates pituitary growth hormone release by binding GHRH receptors, enhancing IGF-1 production to promote muscle growth, fat loss, and tissue repair. Modified with a drug affinity complex (DAC) or as Mod GRF (1-29) without DAC, it extends half-life for sustained GH secretion, improving metabolism and bone density.
The products offered on this website are furnished for in-vitro studies (Latin:in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
